Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1998-12-17
|
pubmed:abstractText |
The interactions of CD28-B7 and CD40-CD40 ligand (CD40L) pathways in T cell costimulation and autoimmune disease are incompletely understood. We sought to address this issue by investigation of the genesis of acetylcholine receptor (AChR)-induced antibody-mediated experimental autoimmune myasthenia gravis (EAMG) in CD28- and CD40L-deficient mice (CD28-/-, CD40L-/-). Compared to wild-type mice, the CD28-/- mice became less susceptible, and CD40L-/- mice were completely resistant to EAMG induction. Analysis of T helper functions, reflected by cytokine responses, revealed a switch to a Th1 profile in CD28-/- mice. Consistently, levels of serum AChR-specific antibodies of the IgG1 isotype were decreased in CD28-/- mice. In the CD40L-/- mice, both Th1 and Th2 cytokine responses were diminished, and T cell-dependent AChR-reactive B cell responses were more severely impaired than in the CD28-/- mice. Thus, CD28 and CD40L are differentially required for induction of EAMG.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD28,
http://linkedlifedata.com/resource/pubmed/chemical/CD40 Ligand,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cholinergic
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0014-2980
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3587-93
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:9842901-Amino Acid Sequence,
pubmed-meshheading:9842901-Animals,
pubmed-meshheading:9842901-Antigens, CD28,
pubmed-meshheading:9842901-CD40 Ligand,
pubmed-meshheading:9842901-Immunoglobulin G,
pubmed-meshheading:9842901-Interferon-gamma,
pubmed-meshheading:9842901-Lymphocyte Activation,
pubmed-meshheading:9842901-Membrane Glycoproteins,
pubmed-meshheading:9842901-Mice,
pubmed-meshheading:9842901-Molecular Sequence Data,
pubmed-meshheading:9842901-Myasthenia Gravis,
pubmed-meshheading:9842901-Receptors, Cholinergic
|
pubmed:year |
1998
|
pubmed:articleTitle |
Differential requirements for CD28 and CD40 ligand in the induction of experimental autoimmune myasthenia gravis.
|
pubmed:affiliation |
Division of Neurology, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden. Fu-Dong.Shi@cnsf.ki.se
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|